先瑞达医疗-B(06669)：VERICOR-RS®的注册申请获中国国家药品监督管理局批准

智通财经03-26

智通财经APP讯，先瑞达医疗-B(06669)发布公告，于2024年3月20日，公司收到中国国家药品监督管理局对微导管Vericor-RS®的注册批准。该产品适用于冠脉及外周血管经皮介入手术中，针对狭窄血管病变部位，引导导丝，并为交换导丝和输送生理盐水或诊断造影剂提供通道。Vericor-RS®具有优异的扭转性能，在手术中可以帮助医生通过旋转微导管更好地逆向穿通血管病变部位。公司将适时在中国市场...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2422695655?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-26 19:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2422695655","market":"sh","top_or_hot":-1,"title":"先瑞达医疗-B(06669)：VERICOR-RS®的注册申请获中国国家药品监督管理局批准","media":"智通财经","content":"<div>\n<p>智通财经APP讯，先瑞达医疗-B(06669)发布公告，于2024年3月20日，公司收到中国国家药品监督管理局对微导管Vericor-RS®的注册批准。该产品适用于冠脉及外周血管经皮介入手术中，针对狭窄血管病变部位，引导导丝，并为交换导丝和输送生理盐水或诊断造影剂提供通道。Vericor-RS®具有优异的扭转性能，在手术中可以帮助医生通过旋转微导管更好地逆向穿通血管病变部位。公司将适时在中国市场...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1092600.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>先瑞达医疗-B(06669)：VERICOR-RS®的注册申请获中国国家药品监督管理局批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n先瑞达医疗-B(06669)：VERICOR-RS®的注册申请获中国国家药品监督管理局批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-26 19:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1092600.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，先瑞达医疗-B(06669)发布公告，于2024年3月20日，公司收到中国国家药品监督管理局对微导管Vericor-RS®的注册批准。该产品适用于冠脉及外周血管经皮介入手术中，针对狭窄血管病变部位，引导导丝，并为交换导丝和输送生理盐水或诊断造影剂提供通道。Vericor-RS®具有优异的扭转性能，在手术中可以帮助医生通过旋转微导管更好地逆向穿通血管病变部位。公司将适时在中国市场...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1092600.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RS","symbol_name":"Reliance Steel & Aluminum Co","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1092600.html","article_id":"2422695655","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2422695655","pubTimestamp":1711452643,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，先瑞达医疗-B(06669)发布公告，于2024年3月20日，公司收到中国国家药品监督管理局对微导管Vericor-RS®的注册批准。该产品适用于冠脉及外周血管经皮介入手术中，针对狭窄血管病变部位，引导导丝，并为交换导丝和输送生理盐水或诊断造影剂提供通道。Vericor-RS®具有优异的扭转性能，在手术中可以帮助医生通过旋转微导管更好地逆向穿通血管病变部位。公司将适时在中国市场开展营销活动。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"RS":"Reliance Steel & Aluminum Co","BK1587":"次新股","06669":"先瑞达医疗-B","BK1100":"医疗保健设备","BK4006":"钢铁","BK1574":"生物医药B类股"},"translate_title":"Xianruida Medical-B (06669): The registration application of VERICOR-RS ® was approved by National Medical Products Administration of China","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06669":1,"RS":1},"content_text":"智通财经APP讯，先瑞达医疗-B(06669)发布公告，于2024年3月20日，公司收到中国国家药品监督管理局对微导管Vericor-RS®的注册批准。该产品适用于冠脉及外周血管经皮介入手术中，针对狭窄血管病变部位，引导导丝，并为交换导丝和输送生理盐水或诊断造影剂提供通道。Vericor-RS®具有优异的扭转性能，在手术中可以帮助医生通过旋转微导管更好地逆向穿通血管病变部位。公司将适时在中国市场开展营销活动。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422695655"}